Related Experiment Video
Updated: Sep 24, 2025

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Skin bacterial richness and diversity in intensive care unit patients with severe pneumonia
Sifen Lu1, Wengeng Zhang1, Xiaojin Li2
1Precision Medicine Key Laboratory of Sichuan Province and Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
Objectives:
Patients with severe pneumonia admitted to the intensive care unit (ICU) have a high risk of mortality, and the microbiome is likely to affect the outcome of such patients. However, the composition of the skin microbiota of ICU patients with severe pneumonia remains unclear. In this study, on the basis of 16S ribosomal ribonucleic acid sequencing, we explored the difference in skin bacterial richness and diversity between the ICU patient group (PG) with severe pneumonia and the healthy control group (CG).
Methods:
The diversity index and taxonomic distribution of skin bacteria were analyzed using the Quantitative Insights Into Microbial Ecology (QIIME) bioinformatics pipeline. Blood, endotracheal aspirate, and bronchoalveolar lavage fluid samples were collected from the same PG subjects for culture.
Results:
Compared with the CG, the diversity of skin bacteria in the PG decreased significantly. Staphylococcus, Acinetobacter, Stenotrophomonas, Enterococcus, Halomonas, and Brevibacillus were differentially abundant in the PG, and most of these bacteria were also identified in the cultures of upper respiratory tract samples of the same PG.
Conclusion:
We provide evidence that healthcare-associated infection in ICU patients with severe pneumonia is strongly associated with skin microbiota, which necessitates the prevention and control of skin bacterial pathogens for these patients.
Insights
Severe pneumonia patients in the intensive care unit (ICU) show reduced skin bacterial diversity. This skin microbiota alteration is linked to healthcare-associated infections, highlighting the need for pathogen control.
Area of Science:
- Microbiology
- Intensive Care Medicine
- Infectious Diseases
Background:
- Patients with severe pneumonia in intensive care units (ICUs) face high mortality risks.
- The role of the skin microbiome in ICU patient outcomes, particularly those with severe pneumonia, is not well understood.
- Understanding skin bacterial composition is crucial for managing severe pneumonia in ICUs.
Purpose of the Study:
- To investigate differences in skin bacterial richness and diversity between severe pneumonia patients in the ICU and healthy controls.
- To identify specific bacterial taxa that are differentially abundant on the skin of ICU patients with severe pneumonia.
Main Methods:
- 16S ribosomal RNA sequencing was used to analyze skin bacterial communities.
- The Quantitative Insights Into Microbial Ecology (QIIME) pipeline was employed for data analysis.
- Skin bacterial diversity and taxonomic distribution were compared between the patient group (PG) and control group (CG).
Main Results:
- Skin bacterial diversity was significantly lower in the ICU patient group compared to the healthy control group.
- Specific bacteria, including Staphylococcus, Acinetobacter, Stenotrophomonas, Enterococcus, Halomonas, and Brevibacillus, were found in different abundances in the patient group.
- Many of these differentially abundant bacteria were also detected in respiratory tract samples from the same patients.
Conclusions:
- Healthcare-associated infections in ICU patients with severe pneumonia are strongly associated with alterations in the skin microbiota.
- Preventing and controlling skin bacterial pathogens is essential for improving outcomes in these vulnerable patients.
More Related Videos
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology